Finance
Finance
HomeWINT • OTCMKTS
Windtree Therapeutics Inc
$0.013
Mar 3, 3:30:23 PM GMT-5 · USD · OTCMKTS · Disclaimer
StockUS listed securityUS headquartered
Previous close
$0.011
Day range
$0.010 - $0.013
Year range
$0.0078 - $3.48
Market cap
468.25K USD
Avg Volume
355.57K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
SCHE
3.53%
VXUS
3.45%
Financials
Income Statement
Revenue
Net income
(USD)Sep 2025Y/Y change
Revenue
——
Operating expense
3.75M-20.86%
Net income
-28.08M-921.64%
Net profit margin
——
Earnings per share
——
EBITDA
-3.39M28.14%
Effective tax rate
10.89%—
Total assets
Total liabilities
(USD)Sep 2025Y/Y change
Cash and short-term investments
204.00K-91.13%
Total assets
15.98M-47.51%
Total liabilities
27.59M5.97%
Total equity
-11.61M—
Shares outstanding
33.71M—
Price to book
-0.03—
Return on assets
-39.24%—
Return on capital
-449.45%—
Net change in cash
(USD)Sep 2025Y/Y change
Net income
-28.08M-921.64%
Cash from operations
-6.37M1.12%
Cash from investing
-789.00K—
Cash from financing
7.06M1.76%
Net change in cash
-97.00K-119.52%
Free cash flow
-1.82M-168.37%
About
Windtree Therapeutics, Inc. is an American company which was set up in 1992 and now is based in Warrington, Pennsylvania, developing drug products for patients with respiratory disease. The company joined an alliance with Laboratorios del Dr. Esteve, S.A. In 2016, Discovery Laboratories changed name to Windtree Therapeutics, Inc. Wikipedia
Founded
Nov 6, 1992
Employees
14
Search
Clear search
Close search
Google apps
Main menu